CPRX · Catalyst Pharmaceuticals, Inc.
$31.49
+0.00 (+0.00%)
At close · Jul 21
Market Cap
$3.85B
Shares
122.38M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-16 | 2026-07-15 | |
| 8-K | 2026-07-08 | — | |
| 8-K | 2026-06-30 | — | |
| 8-K | 2026-06-23 | 2026-06-22 | |
| 8-K | 2026-05-11 | — | |
| 10-Q | 2026-05-11 | 2026-03-31 | |
| 8-K | 2026-05-07 | 2026-05-06 | |
| 10-K/A | 2026-04-30 | 2025-12-31 | |
| 8-K/A | 2026-03-19 | 2026-03-18 | |
| 8-K | 2026-03-18 | — | |
| 10-K | 2026-02-25 | 2025-12-31 | |
| 8-K | 2026-02-25 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-11-05 | — | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-10-01 | — | |
| 8-K/A | 2025-08-28 | 2025-08-25 | |
| 8-K | 2025-08-25 | — | |
| 8-K | 2025-08-07 | 2025-08-06 | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-08-06 | — | |
| 8-K | 2025-08-04 | 2025-08-01 | |
| 8-K | 2025-06-02 | 2025-06-01 | |
| 8-K | 2025-05-23 | 2025-05-20 | |
| 8-K | 2025-05-07 | — | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| DEF 14A | 2025-04-11 | 2025-05-20 | |
| 8-K | 2025-04-09 | 2025-04-08 | |
| 10-K | 2025-02-26 | 2024-12-31 | |
| 8-K | 2025-02-26 | — | |
| 8-K | 2025-01-24 | 2025-01-17 | |
| 8-K | 2025-01-21 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2025-01-08 | — | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-11-06 | — | |
| 8-K | 2024-09-26 | 2024-09-24 | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-08-07 | — | |
| 8-K | 2024-07-26 | 2024-07-24 | |
| 8-K | 2024-05-30 | — | |
| 8-K | 2024-05-21 | — | |
| 8-K | 2024-05-08 | — | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| DEF 14A | 2024-04-10 | 2024-05-21 | |
| 8-K | 2024-03-13 | — | |
| 8-K | 2024-02-29 | 2024-02-28 | |
| 10-K | 2024-02-28 | 2023-12-31 | |
| 8-K | 2024-02-21 | — | |
| 8-K | 2024-01-09 | — |
Showing 1–50 of 152 filings
Key facts
CIK
1369568
CUSIP
14888U101
13F (30d)
59 filings
59 filers
Visit website
Investor relations